NCT06400537View on ClinicalTrials.gov

Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus

PHASE1RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL

A-319

A-319 will be dosed according to the assigned group.

Trial Locations (2)

430000

RECRUITING

Wuhan Union Hospital, Wuhan

030032

RECRUITING

Shanxi Bethune Hospital, Taiyuan

All Listed Sponsors
collaborator

ITabMed Co., Ltd.

INDUSTRY

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER